Docelieva RTU Injection 20mg (Docetaxel): Advanced Cytotoxic Therapy for Global Oncology Docelieva RTU (Ready-To-Use) 20 mg Injection is a sophisticated chemotherapeutic agent containing the active pharmaceutical ingredient Docetaxel. As a member of the taxane family, Docetaxel is a cornerstone of modern oncological treatment, prized for its ability to target and neutralize rapidly dividing malignant cells. Manufactured to international standards, Docelieva RTU is designed for precise, efficient administration in clinical settings, making it a preferred choice for oncology centers worldwide. Therapeutic Indications: Broad Spectrum Cancer Management Breast Cancer: Used both as adjuvant treatment for operable node-positive/negative breast cancer and as a therapy for locally advanced or metastatic breast cancer. Non-Small Cell Lung Cancer (NSCLC): A critical treatment for patients with locally advanced or metastatic disease, often used where previous chemotherapy has failed or as a first-line combination therapy. Prostate Cancer: Indicated in combination with prednisone or prednisolone for the treatment of metastatic castration-resistant prostate cancer and hormone-sensitive prostate cancer. Gastric Adenocarcinoma: Used in combination with cisplatin and 5-fluorouracil for patients with metastatic gastric or gastroesophageal junction adenocarcinoma. Head and Neck Cancer: Employed in induction treatment protocols for locally advanced squamous cell carcinoma. Mechanism of Action: How Docelieva RTU Works Binding to Beta-Tubulin: The drug binds with high affinity to the beta-tubulin subunit of the cell's cytoskeleton. Stabilization of Microtubules: It promotes the polymerization of tubulin, preventing the natural disassembly (depolymerization) of microtubules. Mitotic Arrest: By freezing the cell’s internal machinery, it prevents the mitotic spindle from functioning properly. This “locks“ the cancer cell in the metaphase of division. Apoptosis (Programmed Cell Death): Because the cell cannot complete division, it triggers a cascade leading to programmed cell death, effectively reducing tumor size and halting cancer spread. Professional Administration & Safety Guidelines Pre-medication Protocol: To manage potential hypersensitivity reactions (such as fluid retention, rash, or breathing difficulties), a standard pre-medication regimen—typically involving oral corticosteroids like dexamethasone—is required before the infusion. Professional Oversight: Clinical teams must monitor patients for potential side effects, including neutropenia (low white blood cell count), fatigue, peripheral neuropathy, and gastrointestinal reactions. Handling: As a cytotoxic agent, strict safety protocols (PPE) must be followed during handling and disposal. Why Choose Ernest Oncology? 100% Genuine Medication: We source Docelieva RTU directly from GMP-certified channels, ensuring every batch is authentic with an optimal shelf life. Global Export Footprint: Our established supply chain ensures rapid, secure transit to the USA, UK, UAE, Australia, Singapore, South Africa, Europe, Middle East, Africa, and Asia. Specialized Logistics Expertise: We utilize pharmaceutical-grade packaging and efficient transit routes to maintain product stability, essential for sensitive cytotoxic injections. Regulatory & Documentation Support: We handle all necessary export documentation, including Certificates of Analysis (CoA) and required permits, ensuring seamless customs clearance for your medical facility. Bulk Supplier Advantage: As a dedicated distributor, we offer competitive wholesale rates to support oncology hospitals, pharmacy networks, and government health departments. 📞 Contact Ernest Oncology—Pharmaceutical Exporter from India [GROUP OF ERNEST PHARMACEUTICAL PVT. LTD.] 🌐 Websites www.oncologymediciensupplier.com www.ernestimpex.com www.ernestvision.com www.ernestpharmaceuticals.com 📧 Email: exports@ernestpharmaceuticals.com 📦 Business Type: Exporter | Bulk Supplier | Distributor 📲 WhatsApp: +91 93599 02383 🔗 Direct WhatsApp Connection
Washington, USA
08048034998
+919405476170
Chat with us
Chat with us